Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 19, 2019 - Allergan and Amgen announced the launch of Kanjinti (trastuzumab-anns), a biosimilar to Genentech’s Herceptin (trastuzumab).
Download PDF
Return to publications
